FDA daily

FDA daily for Sunday, June 2, 2024

In this issue: 5 device decisions and 9 label changes.

Device clearances and approvals

FDA date:

FDA decided 0 510(k)s and 5 PMA decisions on Sun, May 19.

Browse device clearances and approvals in FDA data →

Label updates

FDA date:

9 drug labels took effect on Sun, May 19. Below: those, and labels carrying a boxed warning.

  • Valsartan

    VALSARTAN · Aurobindo Pharma Limited · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
  • Abacavir and Lamivudine

    ABACAVIR AND LAMIVUDINE · Aurobindo Pharma Limited · ORAL

    Boxed warningHUMAN PRESCRIPTION DRUG
Browse label updates in FDA data →

How the FDA daily is written

Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.

Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.

Read FDA's day. Stock your practice.

Join free with your NPI: wholesale pricing from verified vendors, with the FDA and state rules for each category one click away.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.